Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ALENDRONATE SODIUM USP, with a corresponding US DMF Number 22333.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 28, 2018, and payment made on September 26, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II